[1] Dispenzieri A,POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol, 2019, 94: 812-827.
[2] Warsame R,Yanamandra U, Kapoor P. POEMS syndrome: an enigma. Curr Hematol Malig Rep, 2017, 12: 85-95.
[3] Keddie S, Lunn MP. POEMS syndrome. Curr Opin Neurol, 2018, 31: 551-558.
[4] Zhao H, Cai H, Wang C, et al. Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome. Blood Cancer J, 2018, 8: 37.
[5] Kanai K,Sawai S,Sogawa K, et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology, 2012, 79: 575-582.
[6] Duan MH,Zhou DB, Jiao L,et al. Preliminary study of autologous peripheral blood stem cell transplantation in patients with POEMS syndrome. Zhonghua Xue Ye Xue Za Zhi, 2010, 31: 744-747.
[7] Cook G, Iacobelli S, van Biezen A, et al. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation. Haematologica, 2017, 102: 160-167.
[8] Yang H, Huang X, Cai Q, et al. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone. Orphanet J Rare Dis, 2016, 11: 80. |
